Fact CheckerSign in

NCT06831162Completed

Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices. The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.

Status (registry)
Completed
Study type
Interventional
Enrollment
6928 (actual)
First submitted
13 Feb 2025
Start date
24 Jan 2025
Primary completion date
18 Aug 2026
Lead sponsor
Vanderbilt University Medical Center
NCT number
NCT06831162

What you commit to

  • Study type: Interventional
  • Participants enrolled: 6928
  • From 24 Jan 2025 to the primary completion date, 18 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Hearing impairment
  • Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)

Other

  • Blindness
  • Being near the end of life (hospice or home hospice)

Who the study is looking for

  • 18 years of age or older
  • Completed the health-related social needs (HRSN) screener as part of a primary care visit
  • Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
  • Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
    • ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
  • 18 years of age or older
  • Completed the HRSN screener as part of a primary care visit
  • Diagnosed with type 2 diabetes
  • Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
  • English-speaking

Criteria the registry did not label

  • ELIGIBILITY CRITERIA FOR EHR DATA EXTRACTION

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.